HomeCompareOWSMX vs JNJ

OWSMX vs JNJ: Dividend Comparison 2026

OWSMX yields 8.30% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OWSMX wins by $14.6K in total portfolio value
10 years
OWSMX
OWSMX
● Live price
8.30%
Share price
$17.63
Annual div
$1.46
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.7K
Annual income
$1,403.55
Full OWSMX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — OWSMX vs JNJ

📍 OWSMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOWSMXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OWSMX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OWSMX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OWSMX
Annual income on $10K today (after 15% tax)
$705.79/yr
After 10yr DRIP, annual income (after tax)
$1,193.02/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, OWSMX beats the other by $489.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OWSMX + JNJ for your $10,000?

OWSMX: 50%JNJ: 50%
100% JNJ50/50100% OWSMX
Portfolio after 10yr
$27.3K
Annual income
$1,115.66/yr
Blended yield
4.08%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OWSMX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OWSMX buys
0
JNJ buys
0
No recent congressional trades found for OWSMX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOWSMXJNJ
Forward yield8.30%3.36%
Annual dividend / share$1.46$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$34.7K$20.0K
Annual income after 10y$1,403.55$827.78
Total dividends collected$11.2K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OWSMX vs JNJ ($10,000, DRIP)

YearOWSMX PortfolioOWSMX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,530$830.35$10,676$355.77+$854.00OWSMX
2$13,232$894.78$11,407$389.39+$1.8KOWSMX
3$15,118$959.68$12,198$426.53+$2.9KOWSMX
4$17,201$1,024.73$13,056$467.62+$4.1KOWSMX
5$19,495$1,089.64$13,987$513.12+$5.5KOWSMX
6$22,014$1,154.15$14,998$563.56+$7.0KOWSMX
7$24,773$1,218.01$16,098$619.52+$8.7KOWSMX
8$27,788$1,280.99$17,295$681.69+$10.5KOWSMX
9$31,076$1,342.90$18,599$750.82+$12.5KOWSMX
10$34,655$1,403.55$20,022$827.78+$14.6KOWSMX

OWSMX vs JNJ: Complete Analysis 2026

OWSMXStock

The fund invests in a broad, diversified portfolio of securities of small and medium capitalization companies traded on a principal U.S. exchange or U.S. over-the-counter market, and securities of small and medium capitalization non-U.S. companies in foreign countries, including emerging market countries. Under normal circumstances, the fund invests at least 80% of its net assets, including borrowings for investment purposes, in securities of small and medium capitalization companies.

Full OWSMX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this OWSMX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OWSMX vs SCHDOWSMX vs JEPIOWSMX vs OOWSMX vs KOOWSMX vs MAINOWSMX vs ABBVOWSMX vs MRKOWSMX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.